Navigation Links
Mystery E. coli genes essential for survival of many species

Scientists have shown that E. coli one of the best known and extensively studied organisms in the world remains an enigma that may hold the key to human diseases, such as cancer.

The team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and based at the University of Dundee has examined the genome sequence of this workhorse of the laboratory and spotted three previously unknown genes that, it turns out, are essential for the survival of E. coli and one out of the three could also be implicated in cancer or developmental abnormalities in humans. These mystery genes are also found in numerous other creatures, suggesting a vital role for them across many species. The research will be published in the 1 August edition of the Journal of Bacteriology.

The effort over recent years to sequence genomes of various important species has uncovered many previously unknown genes. This has given scientists the opportunity to choose to study these genes now, rather than waiting for them to make themselves known serendipitously e.g. when they are implicated in disease. Professor Tracy Palmer and her colleagues have taken three genes identified through sequencing of the E. coli genome and studied them to discover their significance.

Professor Palmer said: "Scientists have been studying E. coli genes for many, many years and we thought we knew pretty much all there was to know we certainly didn't expect to find any more genes that are essential for survival!

"Finding out that these genes are essential in E. coli and also appear in the genomes of other species tells us that they are very important indeed. In the case of one of the genes it is also found in the human genome, which makes it especially interesting. The mystery remains as to what they actually do, but whatever it is, it must be really crucial.

"Because we now know that one of these genes is found in humans as well, we might be looking at something that is really important in our development or that might cause disease."

Early indications from Professor Palmer's work suggest that the genes, named yjeE, yeaZ and ygjD could be involved in cell division. ygjD is present in the human genome and also appears to be the key player of the three genes found in E. coli.

Professor Palmer continued: "We've done experiments that show these genes affect how E. coli cells respond to different messages that tell them when to divide. If they do the same thing in humans then any problems with these genes could easily lead to developmental abnormalities or cancer."

Professor Douglas Kell, BBSRC Chief Executive said: "This work is a good example of where having a genome sequence opens up many possible avenues of enquiry. It also makes clear the value of an organised approach to accessing and using genome information. Research focussed on maximising the use of genome sequences will surely, therefore, accelerate discovery of information that is of social and economic importance. BBSRC has committed to such activity through the launch of our new Genome Analysis Centre earlier this month."


Contact: Nancy Mendoza
Biotechnology and Biological Sciences Research Council

Related biology news :

1. Mystery of bat with an extraordinary nose solved
2. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
3. Scientists tackle the mystery of white-nose syndrome in bats
4. Scientists unravel the mystery of white-nose syndrome
5. Research team wins funds to unravel a DNA mystery
6. Genetic sleuth solves glaucoma mystery
7. Life secret exposed: Scientists unlock mystery of molecular machine
8. Biologists solve mystery of black wolves
9. Fishdunnit! Mystery solved
10. Fish guts explain marine carbon cycle mystery
11. Peering inside the skull of a mouse to solve meningitis mystery
Post Your Comments:
(Date:11/17/2015)... Mass. , Nov. 17, 2015 Pressure ... leader in the development and sale of broadly enabling, ... worldwide life sciences industry, today announced it has received ... its $5 million Private Placement (the "Offering"), increasing the ... $4,025,000.  One or more additional closings are expected in ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... PHILADELPIA, PA (PRWEB) , ... November 24, 2015 , ... ... young entrepreneurs at competitive events in five states to develop and pitch their BIG ... student projects from each state are competing for votes to win the title of ...
(Date:11/24/2015)... , November 24, 2015 ... recent market research report released by Transparency Market Research, ... expand at a CAGR of 17.5% during the period ... Testing Market - Global Industry Analysis, Size, Volume, Share, ... global non-invasive prenatal testing market to reach a valuation ...
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list of ... OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic ...
Breaking Biology Technology: